LOGIN

Blogs

Default Image

State Price Transparency Reporting: 4 strategies to reduce the risk of non-compliance

  • 23 November 2022
Read More
Default Image

Starting with the end in mind – creating sustainable access to medicines

  • 9 November 2022
Read More
Default Image

Stairway to Seven: GPI celebrating 7 years in business

  • 29 September 2022
Read More
Default Image

What should drug pricing reforms look like in the United States?

  • By Margaret Labban, PhD
  • 1 June 2022
Read More
Default Image

The growing call for greater transparency into drug prices Guest writer: Kyle Forcier, Model N

  • 20 May 2022
Read More
Default Image

FDA deals significant blow to low-priced Chinese oncology drugs

  • 6 April 2022
Read More
Default Image

Women Scientists behind the COVID-19 vaccines

  • 8 March 2022
Read More
Default Image

Canada’s PMPRB drug pricing reforms face additional legal challenges

  • By Margaret Labban, PhD
  • 24 February 2022
Read More
Default Image

Growing number of US states enacting legislation to lower drug prices

  • By Margaret Labban, PhD
  • 15 February 2022
Read More
Default Image

NICE’s latest reform – why was it needed and what does it mean for innovation?

  • By Sevcan Cigerli
  • 28 January 2022
Read More

Yearly Archives

Stay Informed

Sign up to receive the latest news and trends
straight into your inbox from GPI